The mechanism(s) of the antiaggregatory effects of cryptolepine: The Role of Cyclic Adenosine Monophosphate and Cellular Ca2+
- 1 March 1993
- journal article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 24 (2), 461-469
- https://doi.org/10.1016/0306-3623(93)90333-s
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Ouabain increases the calcium concentration in intracellular stores involved in stimulus-response coupling in human platelets.Circulation Research, 1990
- 1H-NMR and13C-NMR Assignments of Cryptolepine, A 3:4-Benz-δ-carboline Derivative Isolated fromCryptolepis sanguinolentaPlanta Medica, 1990
- Effects of cryptolepine alone and in combination with dipyridamole on a mouse model of arterial thrombosisJournal of Ethnopharmacology, 1989
- Cryptolepine inhibits platelet aggregation in vitro and in vivo and stimulates fibrinolysis ex vivoGeneral Pharmacology: The Vascular System, 1988
- Studies on CryptolepinePlanta Medica, 1983
- Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca‐independent activation for shape‐change and secretionFEBS Letters, 1982
- Human platelet activation in the absence of aggregation: a calcium- dependent phenomenon independent of thromboxane formationBlood, 1982
- Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMPBiochemical Journal, 1978